R&D How to optimise commercial-scale ATMP manufacturing through ... This is the second part of our series, "The ATMP Manufacturer's Guide to Commercialisation and cGMP Compliance".
News Agios mulls early FDA filing for sickle cell therapy Agios is planning to file its sickle cell disease candidate mitapivat with the FDA under the accelerated pathway within the next few months.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
